About
Transdermal Diagnostics Ltd is a UK-based MedTech startup founded in August 2021. The company focuses on developing non-invasive wearable technology for chronic disease diagnosis and management, particularly diabetes. Headquartered in Bristol, it operates as a private limited entity and is a spin-out from the University of Bath. The company's flagship product is the world's first 100% needle-free continuous glucose monitor. This innovative wearable platform features a disposable adhesive skin patch that extracts biological substances through hair follicles, eliminating the need for needles or blood samples. It includes a rechargeable transmitter that communicates wirelessly with a smartphone app. This technology aims to provide an affordable and pain-free solution for continuous glucose monitoring, targeting individuals with Type 1 and Type 2 diabetes, as well as those with prediabetes. Transdermal Diagnostics is committed to making remote health monitoring accessible and empowering users to manage their health proactively.
Technologies
Keywords
Company Information
- Employees11
- Founded2021
- Total Funding$919880
Location
Claverton Down, England, United Kingdom, BA2 7AY
